Brief: Ortho Regenerative Technologies Announces Extension Of FDA Clinical Hold Of Ortho-R Investigational New Drug Application
20/08/2021 13:58
Aug 20 (Reuters) - Ortho Regenerative Technologies Inc
ORTH.CD :
* ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES EXTENSION OF FDA
CLINICAL HOLD OF ORTHO-R INVESTIGATIONAL NEW DRUG APPLICATION
* ORTHO REGENERATIVE TECHNOLOGIES INC - FDA HAS REQUESTED
SUPPLEMENTAL CLARIFICATIONS ON TWO ADVANCED METHODS OF
CHARACTERIZATION OF IMPURITIES
Source text for Eikon: ID:nPn41vNRLa
Further company coverage: ORTH.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chitogenx
See all newsBrief: Chitogenx Announces Signing Of Binding Letter Of Intent With Oligo Medic
Brief: Chitogenx Announces Executive Leadership Changes
Brief: Chitogenx Inc - Study Results To Be Available Q3-24 After Mandatory Post-Surgery Monitoring
Brief: Chitogenx Concludes Enrolment For Its U.S. Phase I/II Rotator Cuff Tear Repair Clinical Trial
Brief: Chitogenx Announces New $2.5 Million Non-Brokered Private Placement Offering And Balance Sheet Restructuring